Специфическая иммунотерапия бронхиальной астмы

1. Адо А.Д., Червинская Т.А., Вылегжанина Т.Г., КасперовичЛ.Л. Гиперреактивность бронхов и специфическая иммунотерапия при пылевой и клещевой бронхиальной астме / / Всесоюзный конгресс по болезням органовдыхания, 2-й: Тезисы докладов.— Челябинск, 1991.— С.52; No 19.

2. Аллергические болезни у детей / Студеникин М.Я., Соколова Т.С., Ботвиньева Б.В. и др.— М.: Медицина, 1986.

3. Горячкина Л .А., Поспелова Р.А., Храмцова Н.Н., Фролова М.К. Особенности специфической гипосенсибилизирующей терапии больных поллинозом / / Препараты и методы для лечения и диагностики аллергии.— М., 1985.— С.35—36.

4. Порошина ЮЛ., Полсачева О.В., Титова С.М., Шустова В.И. Клинико-иммунологическое изучение различных методов специфической иммунотерапии при поллинозах / / Иммунология.— 1985.— No 5.— С.50—54.

5. Фрадкин В.А. Диагностические и лечебные аллергены.— М.: М едицина, 1990.

6. Чучалин А.Г. Актуальные вопросы пульмонологии / / Пульмонология.— 1992.— No 3.— С.6—9.

7. Aalberse R.C., Van der Gaag R., Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization rezults in an IgG4 restricted response / / J. Im m unol.— 1983.— Vol.130.— P .722—725.

8. Adkinson N.F. What we know and what we need to know about immunotherapy for allergic asthma / / Immunotherapy / Ed. U.G.Svendsen, H.J.Malling.— Kobenhavn, 1989.— P.93—105.

9. Bentley AM., Meng Q., Robinson D.S. et al. Increases in activated T Lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/m acrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics / / Am. J. Respir. Cell. Mol. Biol.— 1993.— Vol.8.— P.35—42.

10. Berzovsky J.A., Berkower I.J. Immunogenicity and antigen structure / / Fundamentals of Immunology / Ed. W .E.Paul. 2-nd Ed.— New York: Raven Press, 1989.— P. 169—208.

11. Bousquet J., Hejjaoui A., Clauzel A.-M., Guerin B., Dhiuert H.t Skassa-Brociek W., Michel F.-B. Specific immunotherapy with a stundardized Dermatophagoides pteronissinus extract. II. Prediction of efficacy of immunotherapy / / J. Allergy Clin. Immunol.— 1988.— Vol.82.— P .971—977.

12. Bousquet J., Michel F.-B. Specific immunotherapy in asthma / / ACI News.— 1992.— Vol.4, No 4.— P. 106—109.

13. Bucur J., Dreborg S., Einarsson R., Ljungstedt-Pahlman I., Nilsson J.-E., Persson G. Immunotherapy with dog-sensitive and cat-sensitive asthmatics / / Ann. Allergy.— 1989.— Vol.62.— P .355—361.

14. Canonica G.W., Mingary M.C., Melioli G., Colombatti M., Moretta L. Imbalances of T cell subpopulations in patients with atopic diseases and effect of specific immunotherapy / / J. Immunol.— 1979.— Vol.125, No 6.— P.2669—2673.

15. Chapman M.D. Use of nonstimulatory peptides: A new strategy for immunotherapy? / / J. Allergy Clin. Immunol.— 1991.— Vol.88, No 3, Pt 1.— P.300—302.

16. Corrigan C.J., Kay A.B. T-cells and eosinophils in the pathogenesis of asthma / / Immunol. Today.— 1992.— Vol.13, No 12.— P .501—507.

17. Creticos P.S., Van Metre T.E.Jr., Mardiney M.R., Rosenberg G.L., Norman P.C., Adkinson N.F.Jr. Dose response of IgE and IgG antibodies during ragweed immunotherapy / / J. Allergy Clin. Immunol.— 1984.— Vol.73.— P.94—104.

18. Creticos P.S. Immunotherapy - modulation of inflammation and mediators / / Immunotherapy / Eds U.G.Svendsen, H.J.Malling.— Kobenhavn, 1989.— P .69—76.

19. Debelic M. Factors involved in the selection of patients for immunotherapy / / Selection of Allergic Patients for Immunotherapy. Proceeding 2-nd BRL Kurhaus Workshop on Allergy.— Scheven- ingen, 1988.— P .25—36.

20. Dreborg S., Agrell B., Foucard T., Kjellman N.I., Koivikko A., Nilsson S. A double-blind, multicenter immunotherapy trail in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results / / Allergy.— 1988.— Vol.41, No 2.— P.131—140.

21. Dreborg S., Akerblom E.B. Immunotherapy with monomethoxy- polyethylene glycol modified allergens / / Crit. Rev. Ther. Drug. Carrier. Syst.— 1990.— Vol.6, No 4.— P.315—365.

22. D’Souza M.F., Pepys J., Wells I.D., Tai E., Palmer F., Overell B.G., McGrath I.T., Megson M. Hyposensitization with Dermatophagoides pteronissinus in house dust allergy: a controlled study of clinical and immunological effects / / Clin. Allergy.— 1973.— Vol.3.— P .177—193.

23. Durham S.R., Varney V., Gaga M., Frew A.J., Jacobson M., Kay A.B. Immunotherapy and allergic inflammation / / Clin. Exp. Allergy.— 1991.— Vol.21, No 1.— P.206—210.

24. Ebner H., Neuchrest C., Havelec L., Kraft D. Comparative studies of the effectiveness of specific immunotherapy in housdust mite allergy / / W ien. Klin. W ochenschr.— 1989.— Bd 101, No 15.— S.504—511.

25. Furin M.J., Norman P., Creticos P., Proud D., Kagey-Sobotka A., Lichtenstein L.M., Nuclerio R. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity / / J. Allergy Clin. Immunol.— 1991.— Vol.88, No 1.— P.27—32.

26. Galant S.P. Allergy shots for hay fever / / Postgrad. Med.— 1989.— Vol.85, No 6.— P.203—209.

27. Gurka G.P., Rocklin R. Immunologic responses during allergen- specific immunotherapy for respiratory allergy / / Ann. Allergy.— 1988.— Vol.61, No 10.— P.239—243.

28. Gurka G.P., Ohman J.L., Rosenwasser L.J. Allergen-specific human T cell clones: derivation, specificity, and activation requirements J / J. Allergy Clin. Immunol.— 1989.— Vol.83.— P.945— 954.

29. Haugaard L., Norregaard O.F., Dahl R. In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy [see comments] / / Ibid.— 1991.— Vol.87, No 3.— P.699—702.

30. Hedlin G., Graff-Lonneuig V:, Heilborn H., Lilja G., Norrlind K., Pegelow K.O., Sundín B., Lowenstein H. Immunotherapy with cat and dog-dander extracts in Children and adults with asthma / / Immunotherapy / Eds. U. G. Svendsen, H.J.Malling.-Kobenhavn, 1989.— P .4 9—60.

31. Hedlin G. Treatment with cat allergy vaccines / / Clin. Exp. Allergy.— 1991.— Vol.21, Suppl.l.— P.211—215.

32. Heusser C.H. Modifying activity of memory B cells. Avoiding the risks of SIT / / FISONS Conference Reporter at EAACI.— Paris, 1992.— P.2—3.

33. Horst M., Hejjaoui A., Horst V., Michel F.B., Bousquet J. Doubleblind, placebo-controlled rush immunotherapy with a stan- dartized Alternaria extract / / J. Allergy Clin. Immunol.— 1990.— Vol.85.— P.460—472.

34. Hsieh K.H. Decreased expression of high affinity interleukin 2 receptor after hyposensitization to house dust / / Ann. Allergy.— 1987.— Vol.59, No 1.— P.57—62.

35. Iliopoulos O., Proud D.P., Adkinson N.F., Creticos P.S., Norman P.S., Kagey-Sobotka A., Lichtenstein L.M., Naclerio R.M. Effects of immunotherapy in early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells / / J.Allergy Clin. Immunol.— 1991.— Vol.87, No 4.— P .855—866.

36. Ishizaka K., Joh K., Shibata.R., Wagatsuma Y., Nakanishi M., Tomizawa K., Kojima K., Kandil E., Sakiyama Y'., Matsumoto S. Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome / / Immunology.— 1990.— Vol.70, No 3.— P.414—416.

37. Jarolim E., Poulsen L.K., Stadler B.M., Ritter C., Kraemer R., de Week A. A long-term follow-up study of hyposensitization with im m unoblotting / / J. A llergy Clin. Im m unol.— 1990.— Vol.85.— P.996—1004.

38. Johnstone D.E. Study of the role of antigen dosage in the treatm ent of poollinosis and pollen asthm a J / J. Dis. Child.— 1957.— Vol.94.— P.1—5.

39. Kang Bann C., Jonson J., Morgan C., Chang J.L. The role of immunotherapy in cockroach asthma / / J. Asthma.— 1988.— Vol.25, No. 4.— P.205—218.

40. Kemeny DM., Tomioka H., Tsutsumi A., Koike T., Lessof M.H., Lee T.H. The relationship between anti-IgE auto-antibodies and the IgE response to wasp venom during immunotherapy / / Clin. Exp. Allergy.— 1990.— Vol.20.— P.67—69.

41. Kemeny D.M., Diaz-Sanchez D., Holmes B.J. CD8+ T cells in allergy / / Allergy.— 1992.— Vol.47, No 1.— P.12—21.

42. Kips J.S., Joos G.F., Peleman R.A., Pauwels K.A. Cytokines in asthma — the latest results / / ACI News.— 1992.— Vol.4, No 4.— P.110—112.

43. Le Roux P., Le Luyer B. Accelerated desensitization to Dermatophagoides pteronissinus mites in children with asthma. Results of two years of immunotherapy / / Allerg. Immunol (Paris).— 1991,— Vol.23, No 4.— P.135—142.

44. Leroy B.P., Lachapelle J.M., Somville M.M., Saint-Remy J.M. Injection of allergen-antibody complexes is an effective of atopic dermatitis [see comments] / / Dermatológica.— 1991.— Vol. 182, No2.— P.98—106.

45. Lilja G., Sundín B., Graff-Lonneuig V., Hedlin G., Heilborn H., Norrlind K., Pegelow K.-O., Lowenstein H. Immunotherapy with cat and dog-dander extracts. IY. Effect of 2 years of treatment / / J. Allergy Clin. Immunol.— 1989.— Vol.83, No 1.— P .37—44.

46. Loidolt D., Vassella C.C., de Week A.L., Stadler B.M. The clinical significance of anti-IgE antibodies in the treatment of allergic rhinopathy / / Laryngorhinootologie.— 1990.— Vol.69, No 5.— P.255—259.

47. Machiels J.J., Somville M.A., Lebrun P.M., Lebecque S.J., Jacquemin M.G., Saint-Remy J.M.R. Allergic bronchial asthma due to Dermatophagoides pteronissinus can be efficiently treated by inoculation of allergen-antibody complexes / / J. Clin. Invest.— 1990.— Vol.85.— P. 1024—1035.

48. Machiels J.J., Somville M.A., Jacquemin M.G., Saint-Remy J.M.R. Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy / / Allergy.— 1990.— Vol.45, No 5.— P .335—348.

49. Mailing H.J., Skov P., Stahl K. Diagnosis and immunotherapy of mould allergy / / Ibid.— 1988.— Vol.43, No 3.— P .228—238.

50. Mailing H.J. Immunotherapy with Cladosporium herbarum / / Immunotherapy / Eds. U.G. Svendsen, H.J. Malling.-Kobenhavn, 1989.— P.39—47.

51. McHugh S.M., Ewan P.W. Reduction of increased serum neutrophil chemotactic activity following effective hyposensitization in house dust mite allergy / / Clin. Exp. Allergy.— 1989.— Vol. 19.— P.327—334.

52. Mosbech H. Who will benefit from immunotherapy / / Immunotherapy / Eds. U.G. Svendsen, H.J. Malling.-Kobenhavn, 1989.— P .89—91.

53. Mosbech H., Djurup R., Dreborg S., Poulsen L.K., Skov P.S., Steringer I. Hyposensitization in asthmatics with mPEG-modified and unmodified house dust mite extract. III. Effect on mite-specific immunological parameters and correlation to change in mite-sen- sitivity and symptoms / / Allergy.— 1990.— Vol.45, No 2.— P.130—141.

54. Muller ü., Berchtold E., Helbing A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients / / J. Allergy Clin. Immunol.— 1991. _ Vol.87, No 3.— P .702—709.

55. Naclerio R.M., Proud D., Togias A., Adkinson N.F., Jr., Meyers D.A., Norman P.S., Lichtenstein L.M. Inflammatory mediators in late antigen-induced rhinitis / / N. Engl. J. M ed.— 1985.— Vol.313.— P .65—70.

56. O’Hehir R.E., Mach B., Berte C., Bai V., Quint D. Direct evidence for a functional role of HLA-DRB3 gene products in the recognition of Dermatophagoides spp by helper T cell clones / / Int. Immunol.— 1990.— Vol.2.— P .885—892.

57. O'Hehir R.E., Busch R., Rothbard J.B., Lamb J.R. An in vitro model of peptide-mediated immunomodulation of the human T cell response to Dermatophagoides spp (house dust mite) / / J. Allergy Clin. Immunol.— 1991.— Vol.87.— P.1120—1127.

58. Ohman J.L., Findlay S.R., Leitermann K.M. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro resposes / / Ibid.— 1984.— Vol.74, No 5.— P.230—239.

59. Paty E., de Blic J., Brunet D., Le Bourgeois M., Garcelon M., Paupe J., Scheinmann P. Accelerated desensitization with Dermatophagoides pteronissinus in severe asthmatic children. Evaluation after one year of immunotherapy / / Arch. Fr. Pediatr.— 1990.— Vol.47, No 3.— P .173—179.

60. Persson C.G.A., Svensson C., Greiff L. et al. The use of the nose to study the inflammatory response of the respiratory tract / / Thorax.— 1992.— Vol.47.— P .993—1000.

61. Rak S. The effect of immunotherapy on primary and secondary bronchial hyperresponsiveness in patients with seasonal asthma / / Immunotherapy / Eds. U. G. Svendsen, H.J.Malling.-Kobenhavn, 1989.— P.77—87.

62. Rak S., Bjornson A., Hakanson L., Sorenson S., Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure / / J. Allergy Clin. Immunol.— 1991.— Vol.88, No 6.— P.878—888.

63. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., Corrigan C., Durham S.R., Kay A.B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma / / N. Engl. J. Med.— 1992.— Vol.326.— P.298—304.

64. Robinson D.S., Bentley A.M., Hartnell A., Barkans J., Corrigan C., Durham S.R., Kay A.B. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness / / Thorax.— 1993.— Vol.48.— P.26—32.

65. Romagnani S. Induction of T1 and T2 responses: a key role for the “natural” immune response? / / Immunol. Today.— 1992.— Vol 13, No. 10.— P.379—381.

66. Saint-Remy J.-M.R. Immunotherapy of allergic diseases: A forthcoming therapy / / Acta Clin. Belg.— 1989.— Vol.44, No 6.— P .369—376.

67. Sehon A.H. Carl Prausnitz Memorial lecture. Supression of antibody responses by chemically modified antigens / / Int. Arch. Allergy Appl. Immunol.— 1991.— Vol.94, No 1—4.— P .11—20.

68. Stadler B.M. A new concept for human IgE regulation / / ACI News.— 1991.— Vol.3, No 2.— P.53—57.

69. Stanworth D.R., Jones V.M., Lewin I.V., Nayyar S. Allergy treatment with a peptide vaccine / / Lancet.— 1990.— Vol.336.— P .1279— 1281.

70. Tamir R., Castracane J.M., Rocklin R.E. Generation of supressor cells in atopic patients during immunotherapy that modulate IgE synthesis / / J. Allergy Clin. Immunol.— 1987.— Vol.79.— P .591—598.

71. Thompson R.A. (Ed.), Bousquet J., Cohen S., Frei P.C., Jager L., Lambert P.H., LessofM.H., Loblay R.H., Mailing H.-J., Norman P.S., de Week A.L., Weeke B. The current status of allergen immunotherapy (hyposensitization). Report of a WHO/IUIS working group / / Allergy.— 1989.— Vol.44, No 10.— P.369—379.

72. Turkeltaub P.C. The importance of allergen dose on the safety and efficacy of immunotherapy of ragweed hay fever with standardised short ragweed extracts (Abstract) / / J. Allergy Clin. Immunol.— 1986.— Vol.77.— P.211.

73. Van Bever H.P., Stevens W.J. Suppression of the late asthmatic reaction by hyposensitisation in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) / / Clin. Exp. Allergy.— 1989.— Vol. 19(4), No 7.— P.399—404.

74. Van Metre T.E., Adkinson N.F., Amodio F.J., Kagey-Sobotka A., Norman P.S. A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever / / J. Allergy Clin. Immunol.— 1979.— Vol.66.— P.500—513.

75. Van Metre T.E., Marsh D.G., Adkinspn N.F., Kagey-Sobotka A., Khattignavong A., Norman P.S., Rosenberg G.L. Immunotherapy for cat asthma / / Ibid.— 1988.— Vol.82.— P. 1055—1068.

76. Varney V.A., Gaga M., Frew A.J., Aber V.R., Kay A.B., Durham S.R. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs / / Br. Med. J.— 1991.— Vol.302, No. 6771.— P.265—269.

77. Vervloet D., van der Brempt X., Charpin D., Sirnbaum J. Immunotherapy in allergic respiratory diseases / / Lung.— 1990.— Vol. 168, Suppl.— P .1013—1024.

78. Warner J.O. Scientific theories of immunotherapy / / Selection of Allergic Patients for Immunotherapy. Proceeding 2-nd BRL Kurhaus Workshop on Allergy.-Scheveningen, 1988.— P.51—62.

79. Youlten L.J.F. Immunotherapy — treatment schedules and allergenic formulations / / Ibid.— P .37—40.